Novartis Investigative Site

Granby, Quebec J2G 8Z9

0 studies enrolling now · 4 studies all time

What they study most

Atherosclerosis, Heart Failure With Reduced Ejection Fraction, Hypertension, Relapsing-Remitting Multiple Sclerosis

Studies at this site

• A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation — Running, not enrolling
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early
• Efficacy and Safety of LCZ696A in Patients With Essential Hypertension — Completed